| Dr Thomas Lee Mcneil, MD | |
|
900 N Porter Ave, Suite 212, Norman, OK 73071 | |
| (405) 329-5255 | |
| (405) 329-5244 |
| Full Name | Dr Thomas Lee Mcneil |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 900 N Porter Ave, Norman, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154431435 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 17336 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Lee Mcneil, MD 900 N Porter Ave, Suite 212, Norman, OK 73071 Ph: (405) 329-5255 | Dr Thomas Lee Mcneil, MD 900 N Porter Ave, Suite 212, Norman, OK 73071 Ph: (405) 329-5255 |
News Archive
MESA Group Holdings, a Pantheon Healthcare Group company, today announced the acquisition of French diagnostic imaging service provider Sigil. Complementing MESA's recent business expansion into France with its core Multi-Vendor Service (MVS) and Managed Equipment Service (MES) offerings, the acquisition of Sigil will accelerate the development and adoption of more efficient asset management and medical equipment maintenance service solutions for public and private sector hospitals and imaging centres.
Massachusetts General Hospital investigators have developed a system to accurately track the dynamic process of falling asleep, something has not been possible with existing techniques. In their report in the October issue of the open-access journal PLOS Computational Biology, the research team describes how combining key physiologic measurements with a behavioral task that does not interfere with sleep onset gives a better picture of the gradual process of falling asleep.
An antibiotic therapy known to reduce catheter-related bloodstream infections in hemodialysis patients has been shown for the first time to reduce mortality, according to a Henry Ford Health System study.
Over a quarter of UK patients treated for growth hormone-producing tumours do not achieve 'safe' growth hormone levels, according to a 30 year UK multi-centre study of clinical management of the rare disease acromegaly. The findings by the Society for Endocrinology UK Acromegaly Register, published in the November issue of Clinical Endocrinology, show that drugs to control acromegaly often fail to bring the disease completely under control in routine clinical practice.
› Verified 8 days ago
Limei Yang, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 15951 Little Axe Dr, Norman, OK 73026 Phone: 405-447-0300 Fax: 405-701-7914 | |
Mrs. Dinah Bess L'heureux, PA-C Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2770 Washington Dr Ste 100, Norman, OK 73069 Phone: 405-310-3735 Fax: 405-310-3576 | |
Charito Marcelo, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 320 12th Ave Ne, Norman, OK 73071 Phone: 405-573-3821 Fax: 405-573-8256 | |
Dr. Lori Lynn Hake, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 900 E Main St, Norman, OK 73071 Phone: 405-321-4880 Fax: 405-573-6684 | |
Kanika Manne, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 900 E Main St, Norman, OK 73071 Phone: 405-573-6602 | |
Uzma Zaidi, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 900 E Main St, Norman, OK 73071 Phone: 405-573-6602 Fax: 405-573-6684 |